India is part of the WHO ‘solidarity trials’ for the drug Remdesivir, which has shown encouraging results in serious Covid-19 patients needing enhanced oxygen and ventilator support, and will be able to access any benefits that accrue from the anti-viral medication once it is established for clinical use. The tests showed significant benefits for two-thirds patients with severe symptoms in 4 countries.
from Times of India https://ift.tt/2RADXl1






0 comments:
Post a Comment